In Milan opened the XVI European AIDS Conference
1439  

In Milan opened the XVI European AIDS Conference

Today in Milan opened the XVI European AIDS Conference, taking place on October 25-27. For the discussion of the last results of the scientific and clinical research, the presentation of new approaches to treatment and prevention activities aimed at combating HIV/AIDS, the scientific employees, activists, and representatives of KAP communities from all European region gathered on the conference site in Italy. To share experience, and to present the achievements of ...

October 26, 2017
ECUO  News  
The call of applications to participate in the EECA CAB meeting is opened
1204  

The call of applications to participate in the EECA CAB meeting is opened

The meeting of the Eastern Europe and Central Asia Community Advisory Board (EECA CAB) in an updated format will be held on November 15-16, 2017 in Kyiv, Ukraine. Representatives of patient organizations of the EECA region, regional organizations and pharmaceutical companies are invited to participate in ...

October 20, 2017
News  
School of Speakers: the art of being yourself, not just a “person with HIV”
1347  

School of Speakers: the art of being yourself, not just a “person with HIV”

The Estonian Communities Consortium (Estonian Network of PLWH, PIDEst and VEKLGBT) organized the second training of the "School of Speakers, School of Leadership" series aimed at developing communication skills and effective interaction with media representatives for successful advocacy. The event took place within the framework of ...

October 17, 2017
ECUO  News  
The Medicines Patent Pool and Otsuka Sign Memorandum of Understanding for Paediatric Formulations of Delamanid for Multidrug-Resistant Tuberculosis
1499  

The Medicines Patent Pool and Otsuka Sign Memorandum of Understanding for Paediatric Formulations of Delamanid for Multidrug-Resistant Tuberculosis

The Medicines Patent Pool (MPP) announced that it has signed a Memorandum of Understanding (MoU) with Otsuka to accelerate the development and manufacturing of, and access to, paediatric formulations containing delamanid for multidrug-resistant tuberculosis (MDR-TB). Delamanid 50mg tablet was recently added to the World Health Organization’s Essential ...

October 12, 2017
News